The delayed phase of cisplatin-induced emesis is mediated by the area postrema and not the abdominal visceral innervation in the ferret

Neuroscience Letters

Volumn 465, Issue 1, 2009, Pages 16-20

  Percie du Sert, Nathalie ^a   Rudd, John A ^b   Moss, Raymond ^a   Andrews, Paul L R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Emesis Research Group   (Hong Kong)

Author keywords

Area postrema; Cisplatin; Emesis; Ferret; Vagus

Indexed keywords

CISPLATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DISEASE COURSE; FERRET; INTESTINE INNERVATION; MALE; NONHUMAN; PRIORITY JOURNAL; RETCHING; SENSORY NERVE; SPLANCHNIC NERVE; VAGUS NERVE; VOMITING;

ABDOMEN; ANIMALS; ANTINEOPLASTIC AGENTS; APOMORPHINE; AREA POSTREMA; CASTRATION; CISPLATIN; DRINKING; EATING; FERRETS; LOPERAMIDE; MALE; SPLANCHNIC NERVES; TIME FACTORS; VAGUS NERVE; VISCERA; VOMITING;

EID: 70349211562     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.08.075     Document Type: Article

References (27)

1. Andrews P.L.R., and Davis C.J. Physiology of emesis induced by anti-cancer therapy. In: Reynolds J., Andrews P.L., and Davis C.J. (Eds). Serotonin and the Scientific Basis of Anti-emetic Therapy (1995), Oxford Clinical Communications, Oxford
2. Andrews P.L.R., Davis C.J., Bingham S., Davidson H.I., Hawthorn J., and Maskell L. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can. J. Physiol. Pharmacol. 68 (1990) 325-345
3. Andrews P.L.R., Kovacs M., and Watson J.W. The anti-emetic action of the neurokinin(1) receptor antagonist CP-99,994 does not require the presence of the area postrema in the dog. Neurosci. Lett. 314 (2001) 102-104
4. Bhandari P., Bingham S., and Andrews P.L.R. The neuropharmacology of loperamide-induced emesis in the ferret: the role of the area postrema, vagus, opiate and 5-HT3 receptors. Neuropharmacology 31 (1992) 735-742
5. Borison H.L., and Wang S.C. Physiology and pharmacology of vomiting. Pharmacol. Rev. 5 (1953) 193-230
6. Endo T., Nemoto M., Minami M., Yoshioka M., Saito H., and Parvez S.H. Changes in the afferent abdominal vagal nerve activity induced by cisplatin and copper sulfate in the ferret. Biogenic Amines 11 (1995) 399-407
7. Fukui H., Yamamoto M., Sasaki S., and Sato S. Involvement of 5-HT3 receptors and vagal afferents in copper sulfate- and cisplatin-induced emesis in monkeys. Eur. J. Pharmacol. 249 (1993) 13-18
8. Fukui H., Yamamoto M., and Sato S. Vagal afferent fibers and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs. Jpn. J. Pharmacol. 59 (1992) 221-226
9. Harding R.K., Hugenholtz H., Kucharczyk J., and Lemoine J. Central mechanisms for apomorphine-induced emesis in the dog. Eur. J. Pharmacol. 144 (1987) 61-65
10. Hawthorn J., Ostler K.J., and Andrews P.L.R. The role of the abdominal visceral innervation and 5-hydroxytryptamine M-receptors in vomiting induced by the cytotoxic drugs cyclophosphamide and cis-platin in the ferret. Q. J. Exp. Physiol. 73 (1988) 7-21
11. Hayat M.A. Principles and Techniques of Scanning Electron Microscopy (1974), Van Nostrand Reinhold Co., New York
12. Hesketh P.J. Chemotherapy-induced nausea and vomiting. N. Engl. J. Med. 358 (2008) 2482-2494
13. Horn C.C., Richardson E.J., Andrews P.L.R., and Friedman M.I. Differential effects on gastrointestinal and hepatic vagal afferent fibers in the rat by the anti-cancer agent cisplatin. Auton. Neurosci. 115 (2004) 74-81
14. Knox A.P., Strominger N.L., Battles A.H., and Carpenter D.O. Behavioral studies of emetic sensitivity in the ferret. Brain Res. Bull. 31 (1993) 477-484
15. Kris M.G., Gralla R.J., Clark R.A., Tyson L.B., O'Connell J.P., Wertheim M.S., and Kelsen D.P. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin. J. Clin. Oncol. 3 (1985) 1379-1384
16. Litterst C.L., Gram T.E., Dedrick R.L., Leroy A.F., and Guarino A.M. Distribution and disposition of platinum following intravenous administration of cis-diamminedichloroplatinum(II) (NSC 119875) to dogs. Cancer Res. 36 (1976) 2340-2344
17. Mackay T.W., and Andrews P.L. A comparative study of the vagal innervation of the stomach in man and the ferret. J. Anat. 136 (1983) 449-481
18. McCarthy L.E., and Borison H.L. Cisplatin-induced vomiting eliminated by ablation of the area postrema in cats. Cancer Treat. Rep. 68 (1984) 401-404
19. Miller A.D., and Nonaka S. Mechanisms of vomiting induced by serotonin-3 receptor agonists in the cat: effect of vagotomy, splanchnicectomy or area postrema lesion. J. Pharmacol. Exp. Ther. 260 (1992) 509-517
20. Mutoh M., Imanishi H., Torii Y., Tamura M., Saito H., and Matsuki N. Cisplatin-induced emesis in Suncus murinus. Jpn. J. Pharmacol. 58 (1992) 321-324
21. Rudd J.A., and Andrews P.L.R. Mechanisms of acute and delayed nausea and vomiting induced by anticancer therapies. In: Hesketh P. (Ed). Management of Nausea and Vomiting in Cancer and Cancer Treatment (2005), Jones and Barlett Publishers, Inc.
22. Rudd J.A., Jordan C.C., and Naylor R.J. Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis. Eur. J. Pharmacol. 262 (1994) R1-2
23. Rudd J.A., Jordan C.C., and Naylor R.J. The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret. Br. J. Pharmacol. 119 (1996) 931-936
24. Sam T.S., Cheng J.T., Johnston K.D., Kan K.K., Ngan M.P., Rudd J.A., Wai M.K., and Yeung J.H. Action of 5-HT3 receptor antagonists and dexamethasone to modify cisplatin-induced emesis in Suncus murinus (house musk shrew). Eur. J. Pharmacol. 472 (2003) 135-145
25. Wang S.C., and Borison H.L. A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate and cardiac glycosides. Gastroenterology 22 (1952) 1-12
26. Watanabe Y., Okamoto M., Ishii T., Takatsuka S., Taniguchi H., Nagasaki M., and Saito A. Long-lasting anti-emetic effect of T-2328, a novel NK(1) antagonist. J. Pharmacol. Sci. 107 (2008) 151-158
27. Zaman S., Woods A.J., Watson J.W., Reynolds D.J., and Andrews P.L.R. The effect of the NK1 receptor antagonist CP-99,994 on emesis and c-fos protein induction by loperamide in the ferret. Neuropharmacology 39 (2000) 316-323